Healthy Skepticism Library item: 9048

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: book

Danzon P.
Pharmaceutical Price Regulation: National Policies versus Global Interests
Washington, DC: American Enterprise Institute 1997
http://www.aei.org/books/bookID.190,filter.all/book_detail.asp

Abstract:

The high cost of R&D makes pharmaceuticals vulnerable to aggressive price regulation. Yet even stringent price regulation has not controlled drug expenditures. Public policy, the author states, must balance controlling health care spending today and preserving incentives for innovative R&D for tomorrow.

The author examines the effect of existing foreign regulation on U.S. firms, the major producers of innovative drugs. She explores the indirect spillovers from the regulatory use of international price comparisons and the increasing threat from parallel trade. The analysis concludes that competition promises more efficiency and incentives.

Notes:

Comment from E-drug: “Those who do not know their opponent’s arguments do not completely understand their own.”